Cervicovaginal cytokines, vaginal infection, and preterm birth

American Journal of Obstetrics and Gynecology

Volumn 190, Issue 5, 2004, Pages 1179-

  Andrews, William W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; EDITORIAL; GENITAL TRACT INFECTION; HUMAN; IMMUNE RESPONSE; MEASUREMENT; PREDICTION; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CYTOLOGY; VAGINITIS;

EID: 2542473140     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.04.016     Document Type: Editorial

References (6)

1. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 342:1500-7, 2000
2. Andrews WW, Hauth JC, Goldenberg RL. Infection and preterm birth. Am J Perinatol 17, 357-65, 2000
3. Simhan HN, Caritis SN, Krohn MA, de Tajada BM, Landers DV, Hillier SL. Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy. Am J Obstet Gynecol 2003;189:560-7.
4. Carey JC, Klebanoff MA, Hauth JC, Hillier SL, Thorn EA, Ernest JM, et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. N Eng J Med 2000; 342:534-40.
5. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thorn EA, et al. Failure of metrinidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 2001;345:487-93.
6. Andrews WW, Sibai BM, Thorn EA, Dudley D, Ernest JM, McNellis D, et al. for the NICHD MFMU Network. Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstet Gynecol 2003;101:847-55.